Moderna Inc (MRNA)
Quick ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 1,927,000 | 2,907,000 | 3,205,000 | 6,848,000 | 2,624,000 |
| Short-term investments | US$ in thousands | 5,098,000 | 5,697,000 | 6,697,000 | 3,879,000 | 1,984,000 |
| Receivables | US$ in thousands | — | — | — | — | — |
| Total current liabilities | US$ in thousands | 2,206,000 | 3,015,000 | 4,923,000 | 9,128,000 | 4,389,000 |
| Quick ratio | 3.18 | 2.85 | 2.01 | 1.18 | 1.05 |
December 31, 2024 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($1,927,000K
+ $5,098,000K
+ $—K)
÷ $2,206,000K
= 3.18
The quick ratio of Moderna Inc has shown a positive trend over the years, increasing from 1.05 in December 31, 2020, to 3.18 in December 31, 2024. This indicates that the company's ability to meet its short-term obligations using its most liquid assets has significantly improved. A quick ratio of above 1 suggests that Moderna has an adequate amount of liquid assets to cover its current liabilities, with higher numbers indicating a stronger financial position and liquidity. Therefore, the increasing trend in Moderna's quick ratio reflects positively on the company's financial health and ability to easily meet its short-term obligations.
Peer comparison
Dec 31, 2024